Clinical Trials Logo
  1. Home
  2. Perinatal Asphyxia
  3. NCT02700854

Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2 — HENRIC  

Perinatal Asphyxia Clinical Trial

Official title:
Hypoxic-Ischemic Encephalopathy Therapy Optimization for Better Neuroprotection With Inhalative CO2 in Asphyxiated, Cooled, Mechanically Ventilated Neonates at Risk for Hypocapnia

Clinical Trial Summary

This is a Phase I, open-label, single center trial to evaluate the feasibility and safety of low concentration CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with The hypothesis is that hypocapnia, which is driven by hyperventilation in the presence of metabolic acidosis, is deleterious to the injured brain and can be safely avoided with low concentration CO2 inhalation.

Clinical Trial Description

Specific aims: 1. To test the feasibility of low concentration inhalative CO2 gas mixture (5% CO2 + 95% air) administration to achieve a desired range of pCO2 of 40-60 mmHg in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe hypoxic-ischemic encephalopathy. 2. To test the safety of CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated, cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe hypoxic-ischemic encephalopathy. Term infants (≥ 36 weeks of gestation) will have to be at risk of hypocapnia to be eligible, as defined by a temperature corrected pCO2 ≤ 40 mmHg in blood gas analysis, at any time within six hours of life. The gas mixture will be administered through patient circuits in conventional ventilators. Administered CO2 level will be closely monitored at the inhalation circuit (constant 5% = 36 mmHg). Blood gas samples will be taken hourly to ensure targeted and tolerable pCO2 levels. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02700854
Study type Interventional
Source Semmelweis University
Contact
Status Completed
Phase Phase 1
Start date February 2016
Completion date November 2019
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06322732 - Optimization of Routine Obstetric and Neonatal Care in the Management of Severe Perinatal Asphyxia in Term or Near-term Newborns: Analysis of Sub-optimal Care
Completed NCT05687708 - Effect of Non-nutritive Sucking on Transition to Oral Feeding in Infants With Asphyxia N/A
Completed NCT00062452 - Esophageal Motility and Airway Defenses Among Infants N/A
Recruiting NCT05946681 - Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Completed NCT02002039 - Neuroprotective Role of Erythropoietin in Perinatal Asphyxia Phase 2/Phase 3
Terminated NCT01626924 - A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia Phase 2
Completed NCT04820504 - Augmented Infant Resuscitator to Enhance Newborn Ventilation N/A
Completed NCT02071160 - Melatonin for Neuroprotection Following Perinatal Asphyxia Phase 1/Phase 2
Recruiting NCT06090968 - Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation N/A
Completed NCT03854435 - Determination of Heart Rate in Infants Needing Resuscitation at Birth N/A
Active, not recruiting NCT05349175 - Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement N/A
Completed NCT03968861 - Outcome After 24 Months of Participants in the TOBY Xenon Study
Recruiting NCT05574855 - Evaluation of Haemodynamic in Neonates Treated With Hypothermia"
Completed NCT00624871 - Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy N/A